Written by Charles Gumbley, BHSc (Clinical Nutrition), DipHSc (Western Herbal Medicine)
Last evidence check: 19 July 2026
This article provides general education, not personalised medical advice. PMDD can involve severe depression, agitation, self-harm thoughts or suicidal thoughts. If you or someone you know is in immediate danger, call triple zero (000). For crisis support, call Lifeline on 13 11 14 or Suicide Call Back Service on 1300 659 467.
Key takeaways
- No dietary supplement has enough PMDD-specific evidence to be named the best option for everyone.
- Much of the research on nutrients and chasteberry involves broadly defined cyclical symptoms, not prospectively confirmed cases of this disorder.
- Diagnosis relies on the timing, severity and functional impact of symptoms tracked daily across at least two menstrual cycles.
- Current clinical guidance gives stronger support to a multimodal care plan, which may include psychological care, exercise and clinician-directed medicine or hormonal options.
- Supplementary B6 can cause peripheral neuropathy, while the TGA issued a July 2026 safety alert about rare but potentially severe liver injury linked to ashwagandha.
Conflict disclosure: Nutrition Market sells vitamins and herbal products. This guide does not rank, link or display products. Category links, product feeds, prices and shop calls to action are permanently disabled because PMDD is a diagnosis-specific mental health condition.
What the supplement evidence can and cannot show
The most accurate answer is that there is no established best supplement for this disorder. No product is established as a treatment for PMDD. Jean Hailes lists several nutrients and chasteberry as options that may help, but states that evidence is not sufficient to support their use for this condition. ([1])
That distinction matters. PMS symptoms can overlap with PMDD, but the latter is not simply a stronger version of bloat, cramp or breast tenderness. It is defined by severe cyclical psychological symptoms and functional impairment. A product studied in people with milder cycle-related complaints cannot automatically be presented as care for the disorder. Treating PMS symptoms is not evidence of efficacy for PMDD.
A 2009 evidence review searched for randomised trials of 62 herbs and nutrients promoted for premenstrual disorders. Trials existed for only ten. One mineral had the strongest signal for PMS; chasteberry and B6 had possible signals; evidence for other nutrients, saffron, St John’s wort, soy and vitamin E was preliminary; and evening primrose oil did not show benefit. The studies were too different for a meta-analysis. ([2])
Scroll sideways to read the full table →
| Evidence question | Why it changes the conclusion |
|---|---|
| Was PMDD confirmed with daily ratings? | Retrospective PMS labels can include a different population |
| Were psychological symptoms and function measured? | A reduction in bodily symptoms does not establish benefit for the disorder |
| Was the exact finished product studied? | One extract or salt cannot validate every retail formula |
| Was the sample large enough? | Small trials can produce unstable estimates |
| Were adverse effects and medicines recorded? | A symptom change is not the whole benefit-risk decision |
| Did symptoms remit outside the luteal phase? | Persistent depression or anxiety may be a different condition or premenstrual exacerbation |
Searches for natural treatments should therefore not become a ranked shopping list. They are a prompt to separate diagnosis-specific evidence from older research and to compare any adjunct against a full treatment plan.
PMDD diagnosis comes before self-selection
Treating PMDD safely begins with confirming the cycle-linked pattern and checking for other explanations.
This is a severe cyclical mood disorder. PMDD symptoms usually emerge in the luteal phase after ovulation, improve within a few days after menstruation begins and are minimal in the week after a period. Common symptoms of PMDD can include marked irritability, mood changes, anxiety and depression, hopelessness, tension or feeling out of control. These mood symptoms may occur alongside physical symptoms of PMDD such as bloating, breast discomfort, headache, joint or muscle pain and appetite or sleep changes. ([3])
Research papers may refer to women with PMDD, while contemporary care may use people with PMDD to include everyone who menstruates and can experience the condition. The diagnostic criteria and safety needs do not change with that wording.
The disorder is not thought to result from a simple progesterone deficiency or a general hormone imbalance. Research instead points to altered sensitivity to normal hormonal changes and neuroactive steroids such as allopregnanolone, which interacts with the GABA-A neurotransmitter system. ([4]) This is why a normal hormone blood test does not rule the condition in or out.
A reliable assessment uses prospective daily symptom tracking for at least two cycles. A 2026 clinical overview again identified this as a core practice, while research on the Daily Record of Severity of Problems shows that retrospective reports alone can classify people poorly. ([5]) Record symptoms, impairment, bleeding, sleep, substance use, medicines and major stressors every day, not only during a difficult week.
Scroll sideways to read the full table →
| Pattern | More consistent with | Useful next step |
|---|---|---|
| Severe symptoms confined mainly to the late luteal phase with a symptom-free interval | Dysphoric disorder pattern | Daily ratings and GP or specialist assessment |
| Symptoms present throughout the month but worse premenstrually | Premenstrual exacerbation of another condition | Assess the underlying condition and cyclical change |
| Mainly bodily and milder psychological symptoms | PMS may be more likely | Track and discuss if function is affected |
| Severe symptoms before menstruation with marked functional impairment | PMDD or another condition may be possible | Prospective ratings and clinical assessment |
| New irregular cycles, heavy bleeding, pelvic pain or symptoms after a medicine change | Another gynaecological or medical issue may contribute | Clinical assessment |
| Elevated energy, reduced need for sleep or risky behaviour | Possible bipolar-spectrum or other mood disorder | Prompt mental health assessment |
Symptoms similar to PMDD can occur with major depression, anxiety disorders, bipolar disorder, thyroid disease, perimenopause, substance effects and some gynaecological conditions. Conditions like premenstrual dysphoric disorder require screening for mood disorders, psychiatric conditions and medical causes; this is part of safe care, not a dismissal of cyclical symptoms. The diagnosis of PMS also needs a clear cycle-linked pattern, although its severity and required symptom profile differ.
Vitamins and supplements: calcium, magnesium and B6
Calcium has the clearest older evidence for PMS. A large trial in 466 participants with prospectively documented moderate-to-severe cyclic symptoms tested 1,200 mg of the elemental mineral daily for three cycles and reported improvement across symptom clusters. ([6]) It was not a modern PMDD trial, and the study dose is not a public recommendation.
Before considering supplementation, count food intake and every other product. Kidney disease, kidney-stone history, high blood levels and medicines can change suitability. This mineral can also affect absorption of some medicines. Food-first intake may be enough, while an individual dose should follow a clinical reason.
Magnesium research is smaller and mixed. Some studies report changes in fluid retention or psychological symptoms, but this does not establish a preferred salt or a reliable effect in people with the dysphoric disorder. The glycinate form is not proven superior. Products can cause diarrhoea, and impaired kidney function increases the risk from accumulation.
Vitamin B6 appears in older PMS trials and is involved in neurotransmitter metabolism, including serotonin pathways. That mechanism does not prove that more will improve mood. The TGA warns that supplementary B6 can cause peripheral neuropathy, including tingling, burning or numbness, sometimes at low amounts or when several products are combined. In March 2026, the regulator advised checking multinutrient, mineral and anti-stress formulas for hidden cumulative amounts. ([7])
Vitamin D should be corrected when a deficiency is confirmed for the appropriate health reason, but it is not an established stand-alone intervention. The same applies to zinc, omega-3 fats and a multinutrient. Correcting a nutrient gap and caring for this disorder are different questions.
Herbal supplements: chasteberry, ashwagandha and other claims
Chasteberry, or Vitex agnus-castus, has trials involving symptoms of PMS and appears in some guidelines as a possible complementary option. Products differ in extract, standardisation and amount, so one study cannot validate every formula. It may affect dopaminergic or hormone pathways and needs review with pregnancy plans, breastfeeding, fertility care, an oral contraceptive pill or other hormone medicine.
Ashwagandha is promoted online for stress, anxiety and premenstrual difficulties, but direct trial evidence for the disorder is not established. A TGA safety alert published on 7 July 2026 says medicines and herbal preparations containing Withania somnifera may be associated with liver injury in very rare cases. Some Australian cases required hospital care. People with current or previous liver problems should avoid it, and anyone who develops jaundice, dark urine, unusual fatigue, abdominal pain, nausea or vomiting should stop and seek clinical advice. ([8])
St John’s wort has major interaction potential. It can reduce the effectiveness of some medicines, including contraception, and can create unsafe serotonergic combinations with an antidepressant or other serotonin-active product. It should not be used as a casual substitute for clinician-directed care.
GABA, 5-HTP, maca, taurine and saffron are also promoted as herbal remedies or mood products. Mechanistic claims, testimonials and a trial in a broader premenstrual population do not establish efficacy for this diagnosis. Certain supplements may also interact with one another. Combining several products makes adverse effects, interactions and attribution harder to assess.
Treatment options for PMDD: natural claims versus established care
The 2023 ACOG guideline covers premenstrual disorders and recommends considering multimodal care. Options include psychological counselling, exercise, nutritional measures, patient education and clinician-directed medicines. ([9]) The plan depends on symptom timing, severity, pregnancy intentions, medical history and coexisting mental health needs.
Selective serotonin reuptake inhibitors, known as SSRIs, have substantially stronger diagnosis-specific evidence than supplements. A clinician may consider continuous or luteal-phase SSRI use. A contraceptive is another possible option for selected patients, but psychological response, contraindications and pregnancy plans matter. This article does not name or promote prescription products.
Cognitive behavioural therapy can help people respond to distressing thoughts, relationship strain and predictable high-risk phases. It is not a claim that the disorder is imagined. Specialist gynaecology or reproductive mental health input can be useful when diagnosis is uncertain, symptoms remain severe or first approaches have not helped.
Complementary approaches should not be used as a reason to delay urgent mental health care. A plan can include food, movement, sleep and an agreed adjunct while still using evidence-based psychological or medical care. Each approach should always be considered against severity, safety and the person’s preferences.
Lifestyle changes and daily symptom tracking
Lifestyle changes are not a cure, but they can support physical and mental health and make symptom patterns easier to interpret. Useful foundations include:
- consistent sleep and wake times
- regular meals with protein, fibre and complex carbohydrates
- aerobic and resistance activity adjusted to capacity
- reviewing caffeine and alcohol if they worsen anxiety, sleep or psychological symptoms
- planning workload, childcare and social support for predictable high-risk days
- keeping medicines and supplement use consistent enough to interpret a trial
- recording mood, irritability, energy, sleep, appetite, bodily symptoms and impairment daily.
Choose one change at a time where practical. Record the start date and assess at a pre-agreed point. A good record captures both luteal symptoms and the symptom-free interval, because improvement across the whole menstrual cycle can otherwise be misread.
Many people with this condition describe a rapid shift in how they think and feel. A written plan prepared during a well phase can list warning signs, people to contact, safe places, urgent numbers, medicine instructions and steps to reduce access to means of self-harm. Share it with a trusted person and clinician.
Safety planning for severe PMDD
A severe presentation can include suicidal thoughts and self-harm urges. A 2026 evidence review found elevated suicidality across studies, although definitions, methods and estimates varied and most had quality concerns. No included trial tested an intervention specifically for suicidality. ([10]) A supplement is not an emergency response.
Use this escalation plan:
- Immediate danger or likely action: call 000 or go to the nearest emergency department. Do not stay alone.
- Suicidal thoughts or an escalating crisis: call Lifeline on 13 11 14 or Suicide Call Back Service on 1300 659 467, and contact a trusted person.
- Severe cyclical symptoms without immediate danger: arrange a prompt GP or mental health appointment and bring daily ratings.
- New medicine or supplement reaction: contact a pharmacist or clinician; seek urgent care for severe symptoms.
Healthdirect maintains current national and state crisis contacts. ([11]) Do not wait for menstruation to start if safety is deteriorating.
Supplement questions about cyclical symptoms
What supplements should I take for PMDD?
No universal stack is established. Calcium has the strongest older evidence for broader cycle-related complaints, while other minerals, B6 and chasteberry have weaker or mixed evidence. Some trials report that an intervention may reduce premenstrual symptoms, but diagnosis-specific proof is insufficient and individual safety needs review.
What is the best thing to take for PMDD?
The best next step is an accurate diagnosis and a care plan matched to severity. Established options such as SSRIs, selected cycle-directed care and psychological support have stronger evidence than dietary supplements.
How do I get out of a PMDD spiral?
Use a plan made during a well phase: reduce immediate demands, contact a trusted person, follow clinician-agreed instructions and use crisis support early. Call 000 for immediate danger, Lifeline on 13 11 14 or Suicide Call Back Service on 1300 659 467.
Can B6 help cyclical changes in mood?
Older research suggests a possible symptom signal, but diagnosis-specific evidence is not strong. The TGA warns that supplementary B6 can cause nerve damage, especially when several products are combined.
Does this mineral help with the disorder?
The mineral has mixed evidence for broader cycle-related symptoms and no clearly superior form for this diagnosis. Kidney function, diarrhoea, medicines and duplicate intake affect safety.
Where can I get help with PMDD?
Start with a GP, psychologist, psychiatrist or gynaecologist who understands cycle-linked mood disorders. Bring daily ratings if possible. If you need support during a crisis, use the urgent contacts at the top of this guide rather than waiting for a routine appointment.
Does PMDD get worse with age?
Symptoms can change across reproductive life and may feel different during perimenopause as cycles become less predictable. Worsening or newly persistent symptoms deserve reassessment rather than an automatic increase in supplements.
References
- Jean Hailes for Women’s Health. Premenstrual dysphoric disorder. Jean Hailes
- Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol. 2009;16(3):e407-e429. PubMed
- Queensland Health. Beyond bloating and mood swings: a guide to PMDD. Updated 8 April 2024. Queensland Health
- Hantsoo L, Epperson CN. Allopregnanolone in PMDD: evidence for dysregulated sensitivity to GABA-A receptor-modulating neuroactive steroids. Neurobiol Stress. 2020;12:100213. doi:10.1016/j.ynstr.2020.100213. PubMed
- Lambert ER, Nolan LN, Schmalenberger KM. Gold-standard evidence and best practice guidance for menstrual cycle-informed clinical care: an overview for clinicians. Br J Clin Psychol. 2026. doi:10.1111/bjc.70066. PubMed
- Thys-Jacobs S, et al. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol. 1998;179(2):444-452. PubMed
- Therapeutic Goods Administration. Are you unknowingly taking too much vitamin B6? Published 4 March 2026. TGA
- Therapeutic Goods Administration. Herbal preparations containing Withania somnifera. Safety alert published 7 July 2026. TGA
- American College of Obstetricians and Gynecologists. Management of premenstrual disorders: Clinical Practice Guideline No. 7. Obstet Gynecol. 2023;142(6):1516-1533. doi:10.1097/AOG.0000000000005426. PubMed
- Zhitnik E, et al. Prevalence, risk factors and treatments for suicidality in people living with PMDD: a systematic review. Adm Policy Ment Health. 2026. doi:10.1007/s10488-026-01504-y. PubMed
- Healthdirect. Mental health crisis support. Healthdirect
